Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Weiselberg

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancer Research|October 1, 1988
Pharmacokinetic and phase I evaluation of esorubicin (4'-deoxydoxorubicin) by continuous infusion over forty-eight hours in patients with leukemiaW Kreis, C Rottach, D R Budman, et al.
American Journal of Clinical Oncology|August 1, 1991
Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trialS M Lichtman, D Budman, H Bosworth, et al.
Cancer Research|March 1, 1988
Effect of tetrahydrouridine on the clinical pharmacology of 1-beta-D-arabinofuranosylcytosine when both drugs are coinfused over three hoursW Kreis, K Chan, D R Budman, et al.
Cancer Research|December 1, 1985
Pharmacokinetics of low-dose 1-beta-D-arabinofuranosylcytosine given by continuous intravenous infusion over twenty-one daysW Kreis, F Chaudhri, K Chan, et al.
Age and Ageing|May 1, 1992
Use of cisplatin for elderly patientsS M Lichtman, M Buchholtz, J Marino, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetic evaluation of zeniplatin in humansL C DeMarco, D R Budman, C Lathia, et al.
Leukemia|November 1, 1991
Therapy of refractory/relapsed acute leukemia with cytosine arabinoside plus tetrahydrouridine (an inhibitor of cytidine deaminase)--a pilot studyW Kreis, D R Budman, K Chan, et al.
Investigational New Drugs|August 1, 1990
Phase I trial of intravenous vinzolidine (LY 104208) given on a biweekly dosing scheduleD R Budman, W Kreis, J Behr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II studyC Hudis, M Fornier, L Riccio, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Research|October 1, 1988
Pharmacokinetic and phase I evaluation of esorubicin (4'-deoxydoxorubicin) by continuous infusion over forty-eight hours in patients with leukemiaW Kreis, C Rottach, D R Budman, et al.
American Journal of Clinical Oncology|August 1, 1991
Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trialS M Lichtman, D Budman, H Bosworth, et al.
Cancer Research|March 1, 1988
Effect of tetrahydrouridine on the clinical pharmacology of 1-beta-D-arabinofuranosylcytosine when both drugs are coinfused over three hoursW Kreis, K Chan, D R Budman, et al.
Cancer Research|December 1, 1985
Pharmacokinetics of low-dose 1-beta-D-arabinofuranosylcytosine given by continuous intravenous infusion over twenty-one daysW Kreis, F Chaudhri, K Chan, et al.
Age and Ageing|May 1, 1992
Use of cisplatin for elderly patientsS M Lichtman, M Buchholtz, J Marino, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetic evaluation of zeniplatin in humansL C DeMarco, D R Budman, C Lathia, et al.
Leukemia|November 1, 1991
Therapy of refractory/relapsed acute leukemia with cytosine arabinoside plus tetrahydrouridine (an inhibitor of cytidine deaminase)--a pilot studyW Kreis, D R Budman, K Chan, et al.
Investigational New Drugs|August 1, 1990
Phase I trial of intravenous vinzolidine (LY 104208) given on a biweekly dosing scheduleD R Budman, W Kreis, J Behr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II studyC Hudis, M Fornier, L Riccio, et al.
Pageof 2